Karyopharm Therapeutics Inc. - Common Stock (KPTI)

9.6500
+0.0500 (0.52%)
NASDAQ· Last Trade: Jul 6th, 2:40 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors
Registration Momentum Builds Across the Oncology Pipeline
Issued on behalf of Oncolytics Biotech Inc.
By USA News Group · Via GlobeNewswire · February 17, 2026